These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10023503)

  • 1. Venlafaxine but not bupropion decreases cerebrospinal fluid 5-hydroxyindoleacetic acid in unipolar depression.
    Little JT; Ketter TA; Mathé AA; Frye MA; Luckenbaugh D; Post RM
    Biol Psychiatry; 1999 Feb; 45(3):285-9. PubMed ID: 10023503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression.
    Little JT; Ketter TA; Kimbrell TA; Dunn RT; Benson BE; Willis MW; Luckenbaugh DA; Post RM
    Biol Psychiatry; 2005 Feb; 57(3):220-8. PubMed ID: 15691522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
    Sheline Y; Bardgett ME; Csernansky JG
    J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine or bupropion responders but not nonresponders show baseline prefrontal and paralimbic hypometabolism compared with controls.
    Little JT; Ketter TA; Kimbrell TA; Danielson A; Benson B; Willis MW; Post RM
    Psychopharmacol Bull; 1996; 32(4):629-35. PubMed ID: 8993084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
    Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
    Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
    Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
    Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia.
    Roy A; Pickar D; Linnoila M; Doran AR; Ninan P; Paul SM
    Psychiatry Res; 1985 Aug; 15(4):281-92. PubMed ID: 2415996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
    Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
    Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability.
    Thase ME; Clayton AH; Haight BR; Thompson AH; Modell JG; Johnston JA
    J Clin Psychopharmacol; 2006 Oct; 26(5):482-8. PubMed ID: 16974189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine and bupropion combination therapy in a case of treatment-resistant depression.
    Fatemi SH; Emamian ES; Kist DA
    Ann Pharmacother; 1999 Jun; 33(6):701-3. PubMed ID: 10410184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid monoamine metabolites in fluoxetine-treated patients with major depression and in healthy volunteers.
    De Bellis MD; Geracioti TD; Altemus M; Kling MA
    Biol Psychiatry; 1993 Apr 15-May 1; 33(8-9):636-41. PubMed ID: 7687151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower CSF homovanillic acid levels in depressed patients with a history of alcoholism.
    Sher L; Oquendo MA; Li S; Huang YY; Grunebaum MF; Burke AK; Malone KM; Mann JJ
    Neuropsychopharmacology; 2003 Sep; 28(9):1712-9. PubMed ID: 12825091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
    von Holst H; Lindquist C; Sedvall G
    Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion.
    Horst WD; Preskorn SH
    J Affect Disord; 1998 Dec; 51(3):237-54. PubMed ID: 10333980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central neurochemical ultradian variability in depression.
    Salomon RM; Johnson BW; Schmidt DE
    Dis Markers; 2006; 22(1-2):65-72. PubMed ID: 16410652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of paroxetine on cerebrospinal fluid concentrations of neurotransmitter metabolites in depressed patients.
    Lundmark J; Wålinder J; Alling C; Manniche PM; Dalgaard L
    Eur Neuropsychopharmacol; 1994 Mar; 4(1):1-6. PubMed ID: 7515737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.
    Molchan SE; Lawlor BA; Hill JL; Martinez RA; Davis CL; Mellow AM; Rubinow DR; Sunderland T
    Biol Psychiatry; 1991 Jun; 29(11):1110-8. PubMed ID: 1714776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment.
    Bäckman J; Alling C; Alsén M; Regnéll G; Träskman-Bendz L
    Eur Neuropsychopharmacol; 2000 Sep; 10(5):341-9. PubMed ID: 10974605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A; Nagao T; Ebara T; Sato M; Otsuki S
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.